Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
525
-
Shares change
-
0
-
Total reported value, excl. options
-
$698
-
Price
-
$1.33
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q4 2023
1 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q4 2023.
Co-Diagnostics, Inc. - Common Stock (CODX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 525 shares
of 38.5M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.78M shares), RENAISSANCE TECHNOLOGIES LLC (617K shares), BlackRock Inc. (502K shares), GEODE CAPITAL MANAGEMENT, LLC (294K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (273K shares), Bank of New York Mellon Corp (146K shares), Kestra Advisory Services, LLC (139K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (108K shares), STATE STREET CORP (101K shares), and CITADEL ADVISORS LLC (96.6K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.